Bi Asset Management Fondsmaeglerselskab A United Therapeutics Corp Transaction History
Bi Asset Management Fondsmaeglerselskab A
- $8.88 Billion
- Q1 2025
A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in United Therapeutics Corp stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 83,866 shares of UTHR stock, worth $23.6 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
83,866
Previous 85,242
1.61%
Holding current value
$23.6 Million
Previous $30.1 Million
14.04%
% of portfolio
0.29%
Previous 0.32%
Shares
14 transactions
Others Institutions Holding UTHR
# of Institutions
733Shares Held
43.6MCall Options Held
124KPut Options Held
122K-
Black Rock Inc. New York, NY5.47MShares$1.54 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$1.25 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.68MShares$753 Million13.34% of portfolio
-
State Street Corp Boston, MA2.23MShares$628 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.11MShares$593 Million1.04% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $12.8B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...